ENDRA Life Sciences Inc. - Common Stock (NDRA)
7.4000
+3.9400 (113.87%)
NASDAQ · Last Trade: Jul 8th, 2:43 PM EDT
Detailed Quote
Previous Close | 3.460 |
---|---|
Open | 10.60 |
Bid | 7.390 |
Ask | 7.440 |
Day's Range | 7.000 - 11.96 |
52 Week Range | 2.900 - 170.63 |
Volume | 84,884,520 |
Market Cap | 5.46M |
PE Ratio (TTM) | -0.1300 |
EPS (TTM) | -56.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 273,499 |
Chart
About ENDRA Life Sciences Inc. - Common Stock (NDRA)
Endra Life Sciences Inc is a pioneering medical technology company focused on enhancing non-invasive imaging techniques for better diagnosis and treatment guidance in healthcare. The company specializes in the development of its innovative Thermo Acoustic Imaging technology, which combines ultrasound and thermal imaging to provide real-time insights into tissue and organ function. By enabling clinicians to visualize metabolic conditions more effectively, Endra aims to improve patient outcomes in various areas, including liver health and cancer detection, while also streamlining the imaging process in medical practices. Read More
News & Press Releases
Investor interest builds in speculative micro-cap names under the radar of Wall Street's "Magnificent Seven" ENDRA
Via AB Newswire · July 8, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · July 8, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · July 8, 2025
Via Benzinga · July 8, 2025
Via Benzinga · July 8, 2025
Via Benzinga · July 7, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · July 7, 2025
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in imaging technologies for the early detection and monitoring of metabolic liver disease, today announced that its ongoing multisite pilot study has helped to identify several product enhancements to further improve the performance of its TAEUS® Liver system against the gold standard, MRI. These findings are expected to drive substantial improvements to the device’s probe design and proprietary algorithms, measurably improving diagnostic accuracy and repeatability. These enhancements are currently being implemented and are expected to strengthen the outcomes of the Company’s planned U.S. Food and Drug Administration (“FDA”) De Novo pivotal study.
By ENDRA Life Sciences Inc. · Via Business Wire · June 16, 2025

Via Benzinga · May 30, 2025
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three months ended March 31, 2025.
By ENDRA Life Sciences Inc. · Via Business Wire · May 15, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · May 9, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · May 9, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · May 9, 2025
Via Benzinga · April 29, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · April 25, 2025
These stocks have an unusual volume in today's session
Via Chartmill · April 23, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 23, 2025
Via Benzinga · April 23, 2025